Clinical Trial Update: Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls [Phase 1]

View source ↗

Summary

Phase 1 study of Hydroxynidone Capsules in patients with liver fibrosis and hepatic impairment; the trial is not yet recruiting and is sponsored by Beijing Cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis

Drugs mentioned

• Hydroxynidone Capsules (Hydroxynidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Liver Fibrosis | Phase 1 | Status: NOT_YET_RECRUITING